Document Details
Form
Filing Date
Mar 04, 2024
Document Date
Mar 01, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.
Filer
RIBEIRO RAMIRO
